Skip to main content

Table 2 Clinicopathological characteristics of stage III undifferentiated gastric adenocarcinoma in terms of histology type

From: Clinicopathological characteristics and outcomes in stage I–III mucinous gastric adenocarcinoma: a retrospective study at a single medical center

Parameters

MC (n = 39)

SRCC (n = 261)

PDC (n = 581)

P value

Age (years), mean ± SD

64.5 ± 10.0

60.2 ± 13.7

62.7 ± 14.0

0.019

 Median

66.0

61.0

66.0

 

Sex

   

0.002

 Male

22 (56.4)

128 (49.0)

359 (61.8)

 

 Female

17 (43.6)

133 (51.0)

222 (38.2)

 

Tumor size (cm), mean ± SD

7.6 ± 3.9

6.0 ± 3.7

5.8 ± 3.1

0.006

 Median

7.0

5.0

5.0

 

Type of gastrectomy

   

0.696

 Total

13 (33.3)

96 (36.8)

226 (38.9)

 

 Subtotal

26 (66.7)

165 (63.2)

355 (61.1)

 

Extent of LN dissection

   

0.268

 <D2

13 (33.3)

71 (27.2)

190 (32.7)

 

 ≥D2

26 (66.7)

190 (72.8)

391 (67.3)

 

No. of LN retrieval, mean ± SD

29.2 ± 16.3

30.2 ± 16.2

28.6 ± 14.9

0.373

 Median

25.0

27.0

26.0

 

T status

   

0.627

 T2

2 (5.1)

6 (2.3)

10 (1.7)

 

 T3

1 (2.6)

5 (1.9)

9 (1.5)

 

 T4

36 (92.3)

250 (95.8)

562 (96.8)

 

LN status

    

 N0

2 (5.1)

1 (0.4)

13 (2.2)

0.118

 N1

8 (20.5)

41 (15.7)

86 (14.8)

 

 N2

11 (28.2)

52 (19.9)

136 (23.4)

 

 N3

18 (46.2)

167 (64.0)

346 (59.6)

 

Positive margins (R1 resection)

8 (20.5)

48 (18.4)

84 (14.5)

0.255

Lymphatic invasiona

   

0.442

 No

8 (21.1)

35 (13.5)

88 (15.4)

 

 Yes

30 (78.9)

225 (86.5)

484 (84.6)

 

Vascular invasiona

   

0.767

 No

30 (78.9)

204 (79.1)

439 (76.9)

 

 Yes

8 (21.1)

54 (20.9)

132 (23.1)

 

Perineural invasiona

   

0.003

 No

17 (45.9)

57 (22.2)

175 (30.8)

 

 Yes

20 (54.1)

200 (77.8)

394 (69.2)

 

Complicationsb

8 (20.5)

44 (16.9)

101 (17.4)

0.854

 Surgery-related

8 (20.5)

35 (13.4)

71 (12.2)

0.316

  Leakage

4 (10.3)

19 (7.3)

34 (5.9)

 

  Intra-abdominal abscess

4 (10.3)

12 (4.6)

28 (4.8)

 

  Wound infection

1 (2.6)

4 (1.5)

15 (2.6)

 

  Bleeding

1 (2.6)

8 (3.1)

9 (1.5)

 

  Delayed gastric emptying

0

1 (0.4)

4 (0.7)

 

  Others

0

3 (1.1)

3 (0.5)

 

 Surgery unrelated

1 (2.6)

16 (6.1)

48 (8.3)

0.275

  Pneumonia

0

2 (0.8)

12 (2.1)

 

  Cardiovascular event

0

5 (1.9)

6 (1.0)

 

  Sepsis

0

2 (0.8)

7 (1.2)

 

  Paralytic ileus

0

1 (0.4)

4 (0.7)

 

  Atelectasis

0

0

5 (0.9)

 

  Others

1 (2.6)

18 (6.9)

38 (6.5)

 

Hospital mortality

2 (5.1)

13 (5.0)

32 (5.5)

0.950

Chemotherapy

30 (76.9)

205 (78.5)

423 (72.8)

0.197

  1. Figures are numbers with percentages in parentheses, unless otherwise stated
  2. LN lymph node, MC mucinous carcinoma, SD standard deviation, PDC poorly differentiated carcinoma, SRCC signet ring cell carcinoma
  3. aSome data were missing
  4. bNumber of patients with event